Vivos (RDGL) Long-Term Investments (2010)

Vivos (RDGL) reported Long-Term Investments of $10000.0 for Q4 2010.

Vivos (RDGL) Long-Term Investments (2010) Analysis & Trends

Vivos (RDGL) has 1 years of Long-Term Investments data on file, last reported at $10000.0 in Q4 2010.

For the quarter ending Q4 2010, Long-Term Investments changed N/A year-over-year to $10000.0; the trailing twelve-month figure through Dec 2010 stood at $10000.0 (changed N/A YoY), and the FY2010 full-year result was $10000.0, changed N/A from the prior year.
Long-Term Investments was little changed at $10000.0 in Q4 2010.
In the past five years, Long-Term Investments ranged from a high of $10000.0 in Q4 2010 to a low of $10000.0 in Q4 2010.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Investments (Qtr)
1	Abbott Laboratories	182.32 Bn	175.02 Bn	6.27 Bn	1.09 Bn
2	Stryker	128.75 Bn	125.88 Bn	3.81 Bn	-
3	Medtronic	107.83 Bn	98.61 Bn	6.41 Bn	-
4	Boston Scientific	67.61 Bn	66.15 Bn	3.61 Bn	-
5	Edwards Lifesciences	48.13 Bn	44.45 Bn	1.29 Bn	285.60 Mn
6	Dexcom	28.26 Bn	27.14 Bn	750.30 Mn	-
7	GE HealthCare Technologies	27.78 Bn	25.50 Bn	1.98 Bn	-
8	Smith & Nephew	26.99 Bn	26.41 Bn	-	121.00 Mn
9	Koninklijke Philips	23.92 Bn	20.80 Bn	2.07 Bn	166.25 Mn
10	Vivos	27.16 Mn	25.60 Mn	-3,105.00	-

Historic Data

Download Data

Date	Value
Dec 31, 2010	10,000.00